REPLIGEN Stock Price
$8.695 
Change:
-0.21 -1.15% Volume:
18,219
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 8.96 | Todays Low: 8.53 | Open: 8.9 | Last Close: 8.8
52 Wk High: 9.55 | 52 Wk Low: 3.73 | Todays Pivot: 8.73 | Pre market open: 5.92
Sector: 
Online News For Repligen
|
Repligen Stock Sees Short Interest Move 24.7% Higher - Forbes
Fri, 10 May 2013 19:35The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, which shows a 659,013 share increase in total short interest for Repligen Corp. (NASD: RGEN), to 3,324,779, an increase of 24.72% since 04/15/2013.
|
|
Repligen Reports First Quarter 2013 Financial Results - PharmaLive (press release) (subscription)
Fri, 03 May 2013 18:40WALTHAM, MA - May 2, 2013 - Repligen Corporation (NASDAQ:RGEN) today reported financial results for the first quarter ended March 31, 2013. Below are financial and business highlights for the first quarter of 2013, financial guidance for the year and ...
|
|
REPLIGEN CORPORATION : Repligen to Report First Quarter 2013 Financial ... - 4-traders (press release)
Tue, 23 Apr 2013 23:15WALTHAM, Mass., April 23, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today announced that it will report financial results for the first quarter 2013 on Thursday, May 2, 2013. The Company will issue a press release prior to market ...
|
|
Repligen Corp (RGEN) Releases Quarterly Earnings Results - Mideast Time
Thu, 02 May 2013 16:13Repligen Corp logo Repligen Corp (NASDAQ: RGEN) announced its earnings results on Thursday. The company reported $0.07 earnings per share for the quarter, Analyst Ratings Network reports. The company had revenue of $16.46 million for the quarter, ...
|
|
Semi-Annual Changes to the NASDAQ Biotechnology Index - Wall Street Journal (press release)
Mon, 13 May 2013 12:09... Inc. (Nasdaq:FURX); Hyperion Therapeutics, Inc. (Nasdaq:HPTX); NewLink Genetics Corporation (Nasdaq:NLNK); Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX); Repligen Corporation (Nasdaq:RGEN); Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP); ...
|
|
Joint Effort Seeks Drugs for Autism - New York Times
Thu, 25 Apr 2013 01:13Dr. McCracken said developing effective treatments had been difficult because the underlying causes were poorly understood until the last few years, and some prominent efforts had failed. In 2004, the experimental drug secretin, developed by RepliGen ...
|
RGEN Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Repligen quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for RGEN to choose from. Visit here to build your stock quote widget »
